1. Home
  2. RSLS vs AQB Comparison

RSLS vs AQB Comparison

Compare RSLS & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSLS
  • AQB
  • Stock Information
  • Founded
  • RSLS 2002
  • AQB 1991
  • Country
  • RSLS United States
  • AQB United States
  • Employees
  • RSLS N/A
  • AQB N/A
  • Industry
  • RSLS Medical/Dental Instruments
  • AQB
  • Sector
  • RSLS Health Care
  • AQB
  • Exchange
  • RSLS Nasdaq
  • AQB Nasdaq
  • Market Cap
  • RSLS 3.2M
  • AQB 3.0M
  • IPO Year
  • RSLS 2007
  • AQB N/A
  • Fundamental
  • Price
  • RSLS $3.57
  • AQB $0.75
  • Analyst Decision
  • RSLS Hold
  • AQB Hold
  • Analyst Count
  • RSLS 1
  • AQB 2
  • Target Price
  • RSLS N/A
  • AQB N/A
  • AVG Volume (30 Days)
  • RSLS 43.6K
  • AQB 221.1K
  • Earning Date
  • RSLS 03-31-2025
  • AQB 11-05-2024
  • Dividend Yield
  • RSLS N/A
  • AQB N/A
  • EPS Growth
  • RSLS N/A
  • AQB N/A
  • EPS
  • RSLS N/A
  • AQB N/A
  • Revenue
  • RSLS $8,183,000.00
  • AQB $1,258,512.00
  • Revenue This Year
  • RSLS $17.47
  • AQB N/A
  • Revenue Next Year
  • RSLS $20.00
  • AQB $43.65
  • P/E Ratio
  • RSLS N/A
  • AQB N/A
  • Revenue Growth
  • RSLS N/A
  • AQB N/A
  • 52 Week Low
  • RSLS $3.23
  • AQB $0.47
  • 52 Week High
  • RSLS $29.00
  • AQB $2.79
  • Technical
  • Relative Strength Index (RSI)
  • RSLS 33.36
  • AQB 50.10
  • Support Level
  • RSLS $3.23
  • AQB $0.68
  • Resistance Level
  • RSLS $3.92
  • AQB $0.98
  • Average True Range (ATR)
  • RSLS 0.31
  • AQB 0.09
  • MACD
  • RSLS -0.08
  • AQB -0.00
  • Stochastic Oscillator
  • RSLS 19.21
  • AQB 33.93

About RSLS ReShape Lifesciences Inc.

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: